Utilization of hepatitis C viremic donors for liver transplant recipients without hepatitis C. A veterans transplant center report.
Adnan SaidMatthew WeissAnna VarhelyiRebecca FaragoCristy BallwegJohn RiceParul AgarwalLuis FernandezDavid FoleyPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2020)
HCV D+R- is a practical strategy to expand the pool of donor organs. It shortened waiting time, allowing patients to receive transplants at lower MELD scores. VA liver transplant programs have provided universal and timely access to post-transplant HCV DAA therapy after donor-derived infection.